Restored TDCA and valine levels imitate the effects of bariatric surgery
Creators
- Quante, Markus1
- Iske, Jasper1
- Heinbokel, Timm1
- Desai, Bhavna N.2
- Rodriguez Cetina Biefer, Hector1
- Nian, Yeqi1
- Krenzien, Felix3
- Matsunaga, Tomohisa1
- Uehara, Hirofumi1
- Maenosono, Ryoichi1
- Azuma, Haruhito4
- Pratschke, Johann3
- Falk, Christine S.5
- Lo, Tammy1
- Sheu, Eric1
- Tavakkoli, Ali1
- Abdi, Reza1
- Perkins, David6
- Alegre, Maria-Luisa7
-
Banks, Alexander S.2
- 1. Harvard University
- 2. Beth Israel Deaconess Medical Center
- 3. Charité Universitätsmedizin Berlin
- 4. Osaka Medical and Pharmaceutical University
- 5. Hannover Medical School
- 6. University of Illinois at Chicago
- 7. University of Chicago
Description
Background: Obesity is widespread and linked to various co-morbidities. Bariatric surgery has been identified as the only effective treatment, promoting sustained weight loss and the remission of co-morbidities.
Methods: Metabolic profiling was performed on diet-induced obese (DIO) mice, lean mice, and DIO mice that underwent sleeve gastrectomies (SGx). In addition, mice were subjected to intraperitoneal (i.p.) injections with taurodeoxycholic acid (TDCA) and valine. Indirect calorimetry was performed to assess food intake and energy expenditure. Expression of appetite-regulating hormones was assessed through quantification of isolated RNA from dissected hypothalamus tissue. Subsequently, i.p. injections with a melanin-concentrating hormone (MCH) antagonist and intrathecal administration of MCH were performed and weight loss was monitored.
Results: Mass spectrometric metabolomic profiling revealed significantly reduced systemic levels of TDCA and L-valine in DIO mice. TDCA and L-valine levels were restored after SGx in both human and mice to levels comparable with lean controls. Systemic treatment with TDCA and valine induced a profound weight loss analogous to effects observed after SGx. Utilizing indirect calorimetry, we confirmed reduced food intake as causal for TDCA/valine-mediated weight loss via a central inhibition of the MCH.
Conclusions: In summary, we identified restored TDCA/valine levels as an underlying mechanism of SGx-derived effects on weight loss. Of translational relevance, TDCA and L-valine are presented as novel agents promoting weight loss while reversing obesity-associated metabolic disorders.
Notes
Data availability
All relevant data supporting the findings of this study are available as source data files.Files
elife-62928-v2.pdf
Files
(2.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:0b0a6f0463bfd6c4baa721a6c6edf2d6
|
252.2 kB | Download |
|
Article md5:4fab48928ab9e2c4f2af3431524e00f9 |
2.2 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.7554/eLife.62928
- Other
- oai:uchicago.tind.io:10062
Funding
- National Institutes of Health
- UO-1 A1 132898
- Deutsche Forschungsgemeinschaft
- QU 420/1-1
- Deutsche Forschungsgemeinschaft
- HE 7457/1-1
- Deutsche Forschungsgemeinschaft
- KR 4362/1-1
- Chinese Scholarship Council
- 201606370196
- German Research Foundation
- DFG SFB738 B3
- Osaka Medical Research Foundation for Intractable Diseases
- European Society of Cardiology
- German Academic Exchange Service
- Boston Claude D. Pepper Older Americans Independence Center
- 5P30AG031679-10